Page 5 - Atyr Pharma Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Atyr pharma inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Atyr Pharma Inc Today - Breaking & Trending Today

aTyr Pharma, Inc. (NASDAQ:LIFE) Sees Significant Drop in Short Interest

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant decrease in short interest in January. As of January 15th, there was short interest totalling 177,500 shares, a decrease of 16.3% from the December 31st total of 212,100 shares. Based on an average daily volume of 344,200 shares, the short-interest ratio […] ....

United States , Atyr Pharma Inc , Granite Bay Wealth Management , Squarepoint Ops , Sigma Securities , American Century Companies Inc , Tyr Pharma , Get Free Report , Bay Wealth Management , Street Group , American Century Companies , Century Companies , Tyr Pharma Trading Down , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity

Findings further demonstrate that efzofitimod modulates myeloid cells via the neuropilin-2 (NRP2) receptor to promote a unique anti-inflammatory mechanism.… ....

Atyr Pharma Inc , Tyr Pharma , Reaking News ,

aTyr Pharma, Inc. (NASDAQ:LIFE) Receives $20.75 Consensus PT from Brokerages

Shares of aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year […] ....

United States , Alyeska Investment Group , Tyr Pharma Company Profile , Stonepine Capital Management , Atyr Pharma Inc , Samsara Biocapital , Blackrock Inc , Tyr Pharma , Get Free Report , Capital Management , Tyr Pharma Price , Tyr Pharma Company , Get Free , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,

Brokerages Set aTyr Pharma, Inc. (NASDAQ:LIFE) Target Price at $20.75

ATyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price […] ....

United States , Sigma Securities , American Century Companies Inc , Atyr Pharma Inc , Tyr Pharma Company Profile , Squarepoint Ops , Virtu Financial , Tyr Pharma , Get Free Report , Street Group , American Century Companies , Century Companies , Tyr Pharma Price , Tyr Pharma Company , Get Free , Tyr Pharma Daily , Atyr Pharma , Nasdaq Life ,